Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, stands as a prominent figure in the field of immunotherapy. Serving as the CRI Clinical Accelerator Chair and Associate Director of the CRI Scientific Advisory Council, Dr. Wolchok plays a pivotal role in advancing the understanding and application of immunotherapy in cancer treatment. With an extensive background in oncology, his expertise has significantly contributed to groundbreaking developments in the field. As a thought leader, Dr. Wolchok actively engages in unraveling the complexities of immunotherapy, striving to answer fundamental questions about its mechanisms and efficacy. Through his multifaceted roles, Dr. Wolchok remains dedicated to driving progress in cancer research and fostering collaborations that accelerate the development of innovative immunotherapeutic approaches.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
